Investigating Patient Satisfaction With Oral Anti-cancer Treatment in Patients With Hormone-receptor Positive, HER2-receptor Negative, Advanced Breast Cancer
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: ER Positive, HER2 Negative Breast Cancer Neoplasms
Sponsor: KU Leuven
Collaborators: Novartis